{"id":"gm-csf-group","safety":{"commonSideEffects":[{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Bone pain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Elevated liver enzymes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"GM-CSF is a cytokine that acts on hematopoietic progenitor cells to promote the differentiation and proliferation of granulocytes and macrophages. By increasing these immune cell populations and enhancing their functional activity, GM-CSF can boost innate and adaptive immune responses. This mechanism is leveraged therapeutically in cancer immunotherapy and to support immune recovery in various clinical contexts.","oneSentence":"GM-CSF (granulocyte-macrophage colony-stimulating factor) stimulates the production and activation of granulocytes and macrophages to enhance immune response.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:47:32.002Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer immunotherapy (Phase 3 indication not fully specified)"}]},"trialDetails":[{"nctId":"NCT04936529","phase":"PHASE2","title":"A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-08-02","conditions":"Neuroblastoma","enrollment":286},{"nctId":"NCT03334305","phase":"PHASE1","title":"Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-05-16","conditions":"Malignant Glioma, High Grade Glioma","enrollment":18},{"nctId":"NCT01757626","phase":"PHASE1, PHASE2","title":"Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-12","conditions":"Neuroblastoma","enrollment":186},{"nctId":"NCT06514898","phase":"PHASE1","title":"Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2025-05-05","conditions":"Recurrent Group 3 Medulloblastoma, Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma","enrollment":12},{"nctId":"NCT03396575","phase":"PHASE1","title":"Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-07-17","conditions":"Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma","enrollment":11},{"nctId":"NCT06757348","phase":"","title":"Fatty Liver and Pancreatic Steatosis","status":"NOT_YET_RECRUITING","sponsor":"Maria Marta Piskorz","startDate":"2025-09-01","conditions":"Exocrine Pancreatic Insufficiency, Fatty Liver, Nonalcoholic, Pancreatic Steatosis","enrollment":61},{"nctId":"NCT06013618","phase":"PHASE2","title":"Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma","status":"RECRUITING","sponsor":"Sun Yat-Sen University Cancer Center","startDate":"2023-06-19","conditions":"Neuroblastoma","enrollment":120},{"nctId":"NCT01309230","phase":"PHASE2","title":"A Trial of FANG™ Vaccine for Participants With Ovarian Cancer","status":"COMPLETED","sponsor":"Gradalis, Inc.","startDate":"2011-03-08","conditions":"Ovarian Cancer","enrollment":39},{"nctId":"NCT02334865","phase":"PHASE1","title":"SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2017-04-13","conditions":"Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma","enrollment":18},{"nctId":"NCT03600350","phase":"PHASE2","title":"pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2018-09-10","conditions":"Prostate Cancer","enrollment":19},{"nctId":"NCT01903330","phase":"PHASE2","title":"ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme","status":"ACTIVE_NOT_RECRUITING","sponsor":"Epitopoietic Research Corporation","startDate":"2014-03","conditions":"Glioblastoma, Gliosarcoma","enrollment":84},{"nctId":"NCT06173219","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.","status":"RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2025-08-01","conditions":"Advanced Solid Tumor","enrollment":38},{"nctId":"NCT05266001","phase":"PHASE3","title":"GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS","status":"TERMINATED","sponsor":"Nationwide Children's Hospital","startDate":"2022-06-14","conditions":"Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome","enrollment":141},{"nctId":"NCT03686683","phase":"PHASE3","title":"Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer","status":"COMPLETED","sponsor":"Dendreon","startDate":"2018-10-18","conditions":"Adenocarcinoma of the Prostate","enrollment":532},{"nctId":"NCT00901511","phase":"PHASE2","title":"Inhaled GM-CSF Therapy of Autoimmune PAP","status":"COMPLETED","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2009-07","conditions":"Autoimmune Pulmonary Alveolar Proteinosis","enrollment":18},{"nctId":"NCT06472739","phase":"PHASE2","title":"The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-09-15","conditions":"GM-CSF","enrollment":138},{"nctId":"NCT00799110","phase":"PHASE2","title":"Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2008-08","conditions":"Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer","enrollment":23},{"nctId":"NCT06345599","phase":"PHASE1, PHASE2","title":"PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study)","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2024-05-01","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":66},{"nctId":"NCT04408092","phase":"EARLY_PHASE1","title":"Study of the Effect of GM-CSF on Macrophages in Ependymoma","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2013-06-25","conditions":"Ependymoma, Recurrent Childhood, Ependymoma","enrollment":6},{"nctId":"NCT03559413","phase":"PHASE1, PHASE2","title":"Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL","status":"COMPLETED","sponsor":"University Children's Hospital Tuebingen","startDate":"2016-06","conditions":"Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults","enrollment":30},{"nctId":"NCT05344209","phase":"PHASE2","title":"Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"Vestre Viken Hospital Trust","startDate":"2022-08-12","conditions":"Oncology, NSCLC Stage IV, NSCLC, Stage III","enrollment":138},{"nctId":"NCT06047860","phase":"PHASE2","title":"A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2023-06-16","conditions":"Advanced Solid Tumor, Refractory Tumor","enrollment":30},{"nctId":"NCT02595060","phase":"PHASE2","title":"Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Inhalation to Improve Host Defense and Pulmonary Barrier Restoration","status":"COMPLETED","sponsor":"University of Giessen","startDate":"2016-06-01","conditions":"ARDS","enrollment":45},{"nctId":"NCT00458653","phase":"PHASE1","title":"Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2005-04","conditions":"Multiple Myeloma","enrollment":45},{"nctId":"NCT03495921","phase":"PHASE3","title":"A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide","status":"TERMINATED","sponsor":"Gradalis, Inc.","startDate":"2018-08-21","conditions":"Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic","enrollment":32},{"nctId":"NCT00005835","phase":"PHASE1","title":"N99-02: Melphalan and Buthionine Sulfoximine","status":"COMPLETED","sponsor":"New Approaches to Neuroblastoma Therapy Consortium","startDate":"2001-08","conditions":"Neuroblastoma","enrollment":31},{"nctId":"NCT05790447","phase":"PHASE2","title":"Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2023-04-01","conditions":"Advanced Solid Tumor, Refractory Tumor","enrollment":60},{"nctId":"NCT03012100","phase":"PHASE2","title":"Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academic and Community Cancer Research United","startDate":"2017-03-31","conditions":"Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7","enrollment":280},{"nctId":"NCT03597347","phase":"PHASE2","title":"Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection","status":"TERMINATED","sponsor":"Savara Inc.","startDate":"2019-06-20","conditions":"Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF)","enrollment":14},{"nctId":"NCT02978222","phase":"PHASE2","title":"Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer","status":"TERMINATED","sponsor":"Marker Therapeutics, Inc.","startDate":"2017-07-20","conditions":"Platinum Sensitive Ovarian Cancer, Ovarian Cancer","enrollment":120},{"nctId":"NCT04326920","phase":"PHASE4","title":"Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2020-03-24","conditions":"COVID-19","enrollment":87},{"nctId":"NCT04104594","phase":"NA","title":"Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2020-02-05","conditions":"Nasal Polyps, Chronic Rhinosinusitis With Nasal Polyps, Olfaction Disorders","enrollment":3},{"nctId":"NCT05435768","phase":"","title":"PraG With RANKL Inhibitor for the Treatment of Advanced Multiple Metastatic Solid Tumors","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2022-08-16","conditions":"Metastatic Solid Tumor","enrollment":51},{"nctId":"NCT01715974","phase":"PHASE3","title":"Use of GM-CSF Treatment in Recurrent Implantation Failure","status":"UNKNOWN","sponsor":"Centre for Endocrinology and Reproductive Medicine, Italy","startDate":"2017-12-12","conditions":"Women With Recurrent Implantation Failure in IVF","enrollment":140},{"nctId":"NCT05451420","phase":"NA","title":"Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy","status":"COMPLETED","sponsor":"Henan Provincial People's Hospital","startDate":"2017-12-01","conditions":"Chronic Hepatitis B","enrollment":33},{"nctId":"NCT00072358","phase":"PHASE2","title":"Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-07","conditions":"Neuroblastoma","enrollment":291},{"nctId":"NCT04400929","phase":"PHASE2","title":"Using GM-CSF as a Host Directed Therapeutic Against COVID-19","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2020-06-02","conditions":"COVID, Sars-CoV2, ARDS, Human","enrollment":2},{"nctId":"NCT05292417","phase":"PHASE2","title":"Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2022-03-25","conditions":"Colorectal Neoplasms","enrollment":71},{"nctId":"NCT04849260","phase":"PHASE1, PHASE2","title":"Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma","status":"UNKNOWN","sponsor":"Lee's Pharmaceutical Limited","startDate":"2021-08-26","conditions":"Local Progression or Metastatic Melanoma With Failed First-line Treatment","enrollment":54},{"nctId":"NCT05131711","phase":"PHASE1, PHASE2","title":"Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2021-11-16","conditions":"Recurrent Glioblastoma","enrollment":60},{"nctId":"NCT00111605","phase":"PHASE1","title":"Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":144},{"nctId":"NCT05060120","phase":"","title":"Biomarker Panel in Ovarian Torsion","status":"UNKNOWN","sponsor":"Assuta Ashdod Hospital","startDate":"2021-09-12","conditions":"Ovary Torsion, Adnexal Torsion","enrollment":20},{"nctId":"NCT00293462","phase":"PHASE3","title":"GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer","status":"COMPLETED","sponsor":"Marilyn Dodd","startDate":"2005-06-07","conditions":"Head and Neck Cancer, Mucositis Oral, Radiation Toxicity","enrollment":91},{"nctId":"NCT04774432","phase":"NA","title":"Effect of GM-CSF on CAPA-IVM System Success Rates in PCOS","status":"UNKNOWN","sponsor":"Mỹ Đức Hospital","startDate":"2021-03-10","conditions":"IVF, PCOS, IVM","enrollment":100},{"nctId":"NCT01409915","phase":"PHASE2","title":"Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2011-03","conditions":"Alzheimer's Disease","enrollment":44},{"nctId":"NCT00515528","phase":"PHASE2","title":"Vaccination Plus Ontak in Patients With Metastatic Melanoma","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2007-04-23","conditions":"Melanoma","enrollment":17},{"nctId":"NCT02562755","phase":"PHASE3","title":"Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone","status":"COMPLETED","sponsor":"SillaJen, Inc.","startDate":"2015-10","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":459},{"nctId":"NCT01570036","phase":"PHASE2","title":"Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax","status":"COMPLETED","sponsor":"George E. Peoples","startDate":"2013-05-21","conditions":"Breast Cancer","enrollment":275},{"nctId":"NCT01580696","phase":"PHASE1, PHASE2","title":"Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer","status":"COMPLETED","sponsor":"COL George Peoples, MD, FACS","startDate":"2012-04","conditions":"Ovarian Cancer, Endometrial Cancer, Fallopian Cancer","enrollment":51},{"nctId":"NCT00091286","phase":"EARLY_PHASE1","title":"Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer","status":"TERMINATED","sponsor":"Craig L Slingluff, Jr","startDate":"2003-03-24","conditions":"Colorectal Cancer","enrollment":11},{"nctId":"NCT02019524","phase":"PHASE1","title":"Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients","status":"COMPLETED","sponsor":"COL George Peoples, MD, FACS","startDate":"2013-09-30","conditions":"Breast Cancer, Ovarian Cancer","enrollment":39},{"nctId":"NCT04200040","phase":"PHASE2","title":"A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients","status":"UNKNOWN","sponsor":"OrienGene Biotechnology Ltd.","startDate":"2017-08-27","conditions":"Melanoma (Skin)","enrollment":165},{"nctId":"NCT03123666","phase":"NA","title":"Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2017-04-19","conditions":"Cirrhosis","enrollment":160},{"nctId":"NCT01498328","phase":"PHASE2","title":"A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma","status":"COMPLETED","sponsor":"Celldex Therapeutics","startDate":"2011-12","conditions":"Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma","enrollment":127},{"nctId":"NCT01355393","phase":"PHASE1, PHASE2","title":"Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer","status":"COMPLETED","sponsor":"University of Washington","startDate":"2011-07","conditions":"HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer","enrollment":50},{"nctId":"NCT01408901","phase":"NA","title":"Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2011-09","conditions":"Peripheral Arterial Disease","enrollment":210},{"nctId":"NCT04206358","phase":"PHASE1","title":"Study to Evaluate OrienX010 in Combination With JS001 in the Treatment of Stage IV (M1c) Liver Metastasis From Melanoma","status":"UNKNOWN","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2019-05-13","conditions":"Melanoma","enrollment":30},{"nctId":"NCT03702426","phase":"NA","title":"Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2018-07-23","conditions":"Spontaneous Bacterial Peritonitis","enrollment":120},{"nctId":"NCT03306589","phase":"PHASE1","title":"Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-08-11","conditions":"Arthritis, Rheumatoid","enrollment":12},{"nctId":"NCT01433172","phase":"PHASE1, PHASE2","title":"Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2012-03-26","conditions":"Lung Cancer, Adenocarcinoma","enrollment":73},{"nctId":"NCT02835742","phase":"PHASE2","title":"Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan","status":"COMPLETED","sponsor":"Niigata University Medical & Dental Hospital","startDate":"2016-09-01","conditions":"Pulmonary Alveolar Proteinosis, Autoimmune","enrollment":78},{"nctId":"NCT03435900","phase":"PHASE2","title":"Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis","status":"COMPLETED","sponsor":"Herlev Hospital","startDate":"2018-02-14","conditions":"Appendicitis Perforated","enrollment":13},{"nctId":"NCT00940342","phase":"PHASE2","title":"Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2004-10-12","conditions":"Leukemia","enrollment":130},{"nctId":"NCT01174082","phase":"PHASE2","title":"Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-07-20","conditions":"Myeloma","enrollment":2},{"nctId":"NCT03282188","phase":"PHASE1, PHASE2","title":"REO13 Melanoma With of Without GM-CSF","status":"WITHDRAWN","sponsor":"University of Leeds","startDate":"2017-10","conditions":"Melanoma, Cancer of Skin","enrollment":""},{"nctId":"NCT00938223","phase":"PHASE2","title":"Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma","status":"COMPLETED","sponsor":"Craig L Slingluff, Jr","startDate":"2000-08","conditions":"Melanoma","enrollment":51},{"nctId":"NCT00609739","phase":"PHASE1, PHASE2","title":"Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"1999-06","conditions":"Leukemia","enrollment":1},{"nctId":"NCT02130869","phase":"PHASE1","title":"A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2014-10-10","conditions":"Neuroblastoma, Lymphoma, High-risk Tumor","enrollment":8},{"nctId":"NCT03316651","phase":"PHASE2","title":"Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis","status":"UNKNOWN","sponsor":"Dai Huaping","startDate":"2016-08","conditions":"Pulmonary Alveolar Proteinosis, Treatment","enrollment":60},{"nctId":"NCT00006184","phase":"PHASE2","title":"Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-02-08","conditions":"Multiple Myeloma","enrollment":20},{"nctId":"NCT00471471","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery","status":"COMPLETED","sponsor":"Ahmad Tarhini","startDate":"2008-10","conditions":"Intraocular Melanoma, Malignant Conjunctival Neoplasm, Melanoma (Skin)","enrollment":22},{"nctId":"NCT00448201","phase":"PHASE2","title":"Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2011-01-07","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":71},{"nctId":"NCT01489423","phase":"","title":"Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2013-04-26","conditions":"Melanoma (Skin)","enrollment":270},{"nctId":"NCT00003119","phase":"PHASE3","title":"Surgery in Treating Children With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1998-03","conditions":"Neuroblastoma","enrollment":968},{"nctId":"NCT02940990","phase":"PHASE2","title":"SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations","status":"UNKNOWN","sponsor":"Shanghai Chest Hospital","startDate":"2016-11","conditions":"NSCLC, SBRT, GM-CSF","enrollment":50},{"nctId":"NCT01718210","phase":"PHASE4","title":"Use of GM-CSF Supplemented IVF Medium in Patients With Recurrent Implantation Failure","status":"COMPLETED","sponsor":"Centre for Endocrinology and Reproductive Medicine, Italy","startDate":"2012-12","conditions":"Infertility","enrollment":100},{"nctId":"NCT00613509","phase":"PHASE2","title":"Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2008-06","conditions":"Melanoma, Cancer","enrollment":23},{"nctId":"NCT00066365","phase":"PHASE2","title":"Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-07","conditions":"Metastatic Cancer, Sarcoma","enrollment":49},{"nctId":"NCT00979706","phase":"PHASE4","title":"Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).","status":"COMPLETED","sponsor":"Juan A. Arnaiz","startDate":"2005-03","conditions":"HIV","enrollment":22},{"nctId":"NCT01023256","phase":"PHASE1, PHASE2","title":"Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"MorphoSys AG","startDate":"2009-12","conditions":"Rheumatoid Arthritis","enrollment":96},{"nctId":"NCT02243228","phase":"PHASE2","title":"Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2014-08","conditions":"Autoimmune Pulmonary Alveolar Proteinosis","enrollment":42},{"nctId":"NCT00003955","phase":"PHASE2","title":"Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1999-09","conditions":"Sarcoma","enrollment":77},{"nctId":"NCT00499577","phase":"PHASE1, PHASE2","title":"Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma","status":"COMPLETED","sponsor":"University of Maryland Greenebaum Cancer Center","startDate":"2006-12","conditions":"Multiple Myeloma and Plasma Cell Neoplasm","enrollment":56},{"nctId":"NCT01983657","phase":"PHASE2","title":"Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.","status":"UNKNOWN","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2012-01","conditions":"Pulmonary Alveolar Proteinosis","enrollment":40},{"nctId":"NCT01878565","phase":"PHASE1, PHASE2","title":"The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2013-06","conditions":"Chronic Hepatitis B","enrollment":40},{"nctId":"NCT00004162","phase":"PHASE1","title":"Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"1997-06","conditions":"Lymphoma","enrollment":48},{"nctId":"NCT00928902","phase":"PHASE2","title":"Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma","status":"COMPLETED","sponsor":"University of Virginia","startDate":"1999-11","conditions":"Melanoma","enrollment":41},{"nctId":"NCT01176552","phase":"PHASE2","title":"Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer","status":"COMPLETED","sponsor":"Kidney Cancer Research Bureau","startDate":"2004-05","conditions":"Renal Cell Carcinoma","enrollment":35},{"nctId":"NCT00973128","phase":"PHASE2","title":"Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"Hospital Universitário Professor Edgard Santos","startDate":"2004-02","conditions":"Cutaneous Leishmaniasis","enrollment":40},{"nctId":"NCT00925873","phase":"PHASE3","title":"GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly","status":"COMPLETED","sponsor":"French Innovative Leukemia Organisation","startDate":"1996-06","conditions":"Acute Myeloid Leukemia","enrollment":303},{"nctId":"NCT00561275","phase":"PHASE1","title":"Safety Study of Multiple Peptide Vaccine to Esophageal Cancer","status":"COMPLETED","sponsor":"Japanese Foundation for Cancer Research","startDate":"2007-10","conditions":"Esophageal Cancer","enrollment":6}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":165,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["GM-CSF"],"phase":"phase_3","status":"active","brandName":"GM-CSF group","genericName":"GM-CSF group","companyName":"Centre for Endocrinology and Reproductive Medicine, Italy","companyId":"centre-for-endocrinology-and-reproductive-medicine-italy","modality":"Small molecule","firstApprovalDate":"","aiSummary":"GM-CSF (granulocyte-macrophage colony-stimulating factor) stimulates the production and activation of granulocytes and macrophages to enhance immune response. Used for Cancer immunotherapy (Phase 3 indication not fully specified).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}